Latest filing published 06 Dec 2019 for Myriad Genetics INC.
Insider track record
No signal scores available.
Closed purchases
Based on 32 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +8.6%Entry US$24.08 · Close at T+365 US$26.15
- -30.6%Entry US$24.45 · Close at T+365 US$16.96
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Lawrence C. Best: trading record in brief
Lawrence C. Best is a declared insider at 4 companies; the most frequent names are Boston Scientific Corp, Haemonetics Corp and Myriad Genetics Inc. We count 174 filings; the first trade dates from 15 February 2006 and the latest from 5 December 2019.
On the open market, the record shows 32 purchases worth €7.5M and 110 sales worth €14.6M. The net balance comes to €7.2M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 19 share grants and 12 option exercises.
In size, the median ticket on the buying side is €103k. Looking at 32 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -4.2%. Past outcomes like these are no guarantee of what comes next.
The newest entry dates from 6 December 2019: a share grant, in Myriad Genetics Inc. The latest purchase dates back some time: it was published 7,447 days ago, on 19 June 2006. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Lawrence C. Best
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,687 shares0Common StockSEC:0001191248-19-000002:0
- 9,360 shares0Common StockSEC:0001191248-18-000002:0
- 7,219 shares0Common StockSEC:0001191248-17-000002:0
- 15,024 shares0Common StockSEC:0001191248-16-000004:0
- 7,500 shares0Common StockSEC:0001191248-15-000002:0
- 10,000 shares0Common StockSEC:0001191248-14-000004:0
- 4,184 shares@ US$24.96Common StockSEC:0000313143-14-000067:0
- 4,184 shares@ US$33.91Common StockSEC:0000313143-14-000067:1
- 5,000 shares@ US$24.96Common StockSEC:0000313143-14-000067:2
- 5,000 shares@ US$33.91Common StockSEC:0000313143-14-000067:3
- 1,649 shares0Common StockSEC:0000313143-13-000139:0
- 12,000 shares@ US$26.38Common StockSEC:0000313143-13-000080:0
- 12,000 shares@ US$38.32Common StockSEC:0000313143-13-000080:1
- 1,031 shares@ US$0.01Common StockSEC:0000313143-12-000111:0
- 100,000 shares@ US$24.58Common StockSEC:0001191248-11-000002:0
- 15,305 shares@ US$20.47Common StockSEC:0000313143-11-000009:0
- 15,305 shares@ US$61.06Common StockSEC:0000313143-11-000009:1
- 6,000 shares@ US$44.74Common StockSEC:0000313143-11-000009:2
- 6,000 shares@ US$61.65Common StockSEC:0000313143-11-000009:3
- 6,000 shares@ US$26.11Common StockSEC:0000313143-11-000009:4
- 6,000 shares@ US$61.94Common StockSEC:0000313143-11-000009:5
- 4,695 shares@ US$20.47Common StockSEC:0000313143-11-000009:6
- 4,695 shares@ US$62.00Common StockSEC:0000313143-11-000009:7
- 25,000 shares@ US$21.49Common StockSEC:0001191248-10-000003:0
- 65,000 shares@ US$21.56Common StockSEC:0001191248-10-000003:1
25 of 170 declarations